Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors

Details for Australian Patent Application No. 2005276132 (hide)

Owner Pfizer Inc.

Inventors Cui, Jingrong Jean; Nambu, Mitchell David; Tran-Dube, Michelle Bich; Jia, Lei; Meng, Jerry Jialun; Pairish, Mason Alan; Shen, Hong; Kung, Pei-Pei; Funk, Lee Andrew

Agent Allens Arthur Robinson

Pub. Number AU-B-2005276132

PCT Pub. Number WO2006/021881

Priority 60/690,803 14.06.05 US; 60/605,244 26.08.04 US

Filing date 15 August 2005

Wipo publication date 2 March 2006

Acceptance publication date 29 September 2011

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4439 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

22 February 2007 PCT application entered the National Phase

  PCT publication WO2006/021881 Priority application(s): WO2006/021881

29 September 2011 Application Accepted

  Published as AU-B-2005276132

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005276135-Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors

2005276117-Peptide inhibitors for mediating stress responses